Bayer Strategy Head: Big Pharma “Needs to Up its Game”
During the FT Global Pharmaceutical and Biotechnology Conference earlier this week, four Big Pharma and biotech executives spoke about the changing…
Tagged with Alnylam
Top 5 RNA-Based Biopharma Companies
Below we present a list of the top 5 public biopharma companies that focus on developing RNA-based therapies. RNA interference (RNAi) is a natural…
Interview: Alicia Folgueira López – General Manager Spain…
Alnylam, pioneers in the RNA interference field, seek to bring their revolutionary medicine across Europe, and in particular Portugal before 2020. In…
